medigraphic.com
ISSN 1727-897X (Electronic)

2019, Number 4

<< Back Next >>

Medisur 2019; 17 (4)

Treatment of pain in oncological patients

Díaz JYL, Hernández OY, Hernández RLA, Cuevas POL, Fernández RDR

Language: Spanish
References: 43
Page: 552-561
PDF size: 196.73 Kb.


ABSTRACT

Uncontrolled oncological pain is one of the symptoms that negatively affect the physical and psychological health of patients diagnosed with cancer. Undoubtedly, it represents a particularly dramatic situation. There is evidence about pain control benefits of in these patients; to achieve them, it is necessary to assess the causes, location, intensity and duration of pain before and during treatment. Different ways of measuring pain intensity are proposed, and the analog visual scale is one of the most common, in addition to being the most used internationally with respect to the rest of the single-dimensional scales. The World Health Organization proposes the use of the analgesic ladder in a prescribed manner, with the corresponding titration of the analgesic need, as well as the necessary coadjutant treatments. Standardizing treatments correctly and evaluating their response, is essential for pain control. The present bibliographic review proposes an overlook to the international guidelines in the therapeutic approach of this condition, and with it, it offers an update on the topic.


REFERENCES

  1. Castañeda AH. Calidad de vida y adherencia al tratamiento de personas con enfermedad crónica oncológica [Tesis]. Bogotá : Universidad Nacional de Colombia; 2014. [ cited 14 Nov 2017 ] Available from: http://bdigital.unal.edu.co/40201/1/539773.2014. pdf.

  2. Yera JL. Dolor agudo o episódico por cáncer. Rev Cuba Anestesiol Reanim [revista en Internet]. 2012 [ cited 7 Mar 2018 ] ; 11 (1): [aprox. 14p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1726-67182012000100009&lng=es.

  3. Álvarez JA, Calvete S, Fernández RM, Guardia J, Henche AI, et al. Guía consenso para el buen uso de los analgésicos opioides [Internet]. Valencia: Sociodrogalcohol; 2017. [ cited 12 Feb 2019 ] Available from: http://www.pnsd.mscbs.gob.es/profesionales/publ icaciones/catalogo/bibliotecaDigital/publicaciones /pdf/2017_GUIA_Buen_uso_opioides_Socidrigalco hol.pdf.

  4. Duthey B, Scholten W. Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. J Pain Symptom Manage. 2014 ; 47 (2): 283-97.

  5. Cleary J, De Lima L, Eisenchlas J, Radbruch L, Torode J, Chermy NI. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol. 2013 ; 24 Suppl 11: Sxi41-50.

  6. Lara A, Ahumada M, Basantes AA, Bistre S, Bonilla P, Duarte ER, et al. Latin-American guidelines for cancer pain managemen. Pain Manag [revista en Internet]. 2017 [ cited 14 May 2018 ] ; 7 (4): [aprox. 40p]. Available from: https://www.futuremedicine.com/doi/10.2217/pm t-2017-0006.

  7. Goss PE, Lee BL, Badovinac T, Strasser K, Chavarri Y, St Louis J, Villarreal C, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013 ; 14 (5): 391-436.

  8. American Cancer Society. Datos y Estadísticas sobre el Cáncer entre los Hispanos/Latinos 2015-2017 [Internet]. Atlanta: American Cancer Society; 2015. [ cited 14 May 2018 ] Available from: https://www.cancer.org/content/dam/cancer-org/r esearch/cancer-facts-and-statistics/cancer-facts-a nd-figures-for-hispanics-and-latinos/datos-y-estad ísticas-sobre-el-cáncer-entre-los-hispanos-latinos2015-2017.pdfl.

  9. Jiménez M. Beneficios y efectos adversos del tratamiento con opioides en el dolor por cáncer [Tesis]. España: Universidad de Jaén; 2015. [ cited 13 Oct 2017 ] Available from: http://tauja.ujaen.es/bitstream/10953.1/1654/1/T FG_Marta_Jimnez_Len.pdf.

  10. International Association for the Study of Pain. Declaration of Montréal 2010 [Internet]. Washington, D.C: IASP; 2010. [ cited 25 Mar 2017 ] Available from: https://www.iasp-pain.org/DeclarationofMontreal.

  11. Larramendi J, Gutiérrez D, Futiel N, Frías JA, Peña M. Intensidad del dolor en pacientes con cáncer según etapas clínicas en el municipio de Manzanillo. MEDISAN [revista en Internet]. 2013 [ cited 12 Mar 2018 ] ; 17 (8): [aprox. 8p]. Available from: http://scieloprueba.sld.cu/scielo.php?script=sci_a rttext&pid=S1029-30192013000800006&lng=es &tlng=es.

  12. Moyano JR. Análisis del consumo de opiáceos en Colombia desde dos perspectivas diferentes [Tesis]. Barcelona: Universidad Autónoma de Barcelona; 2016. [ cited 12 Oct 2017 ] Available from: https://dialnet.unirioja.es/servlet/tesis?codigo=11 6988.

  13. Hernán R. Manejo del dolor en el cáncer. Rev Med Clin Condes [revista en Internet]. 2013 [ cited 12 Mar 2018 ] ; 24 (4): [aprox. 6p]. Available from: https://www.clinicalascondes.cl/Dev_CLC/media/I magenes/PDF revista médica/2013/4 julio/12_Dr.-Rudy-Hern-in-Garrido-L.pdf.

  14. Regueira SM, Fernández MD, Díaz MD. Generalidades del dolor oncológico. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta [revista en Internet]. 2015 [ cited 30 Ene 2018 ] ; 40 (10): [aprox. 16p]. Available from: http://www.revzoilomarinello.sld.cu/index.php/zm v/article/view/343.

  15. Vallath N, Salins N, Kumar M. Unpleasant subjective emotional experiencing of pain. Indian J Palliat Care. 2013 ; 19 (1): 12-9.

  16. Ministerio de Salud Pública del Ecuador. Tratamiento del dolor oncológico en adultos. Guía de Práctica Clínica (GPC) [Internet]. Quito: Dirección Nacional de Normatización; 2017. [ cited 28 Feb 2018 ] Available from: https://www.salud.gob.ec/wp-content/uploads/20 19/02/GPC_dolor_oncologico_adultos_-2017.pdf.

  17. CCO’s Symptom Management Pocket Guides: Pain [Internet]. Ontario: CCO; 2010. [ cited 14 Ene 2018 ] Available from: https://www.cancercareontario.ca/en/system/files _force/symptoms/CCOPainPocketGuide_0.pdf?do wnload=1.

  18. Nersesyan H, Slavin KV. Current aproach to cancer pain management: Availability and implications of different treatment options. Ther Clin Risk Manag [revista en Internet]. 2007 [ cited 16 Nov 2017 ] ; 3 (3): [aprox. 50p]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23 86360/.

  19. Reyes D, Gonzalez J, Mohar A, Meneses A. Epidemiología del dolor por cáncer. Rev Soc Esp Dolor [revista en Internet]. 2011 [ cited 18 Ene 2018 ] ; 18 (2): [aprox. 36p]. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext &pid=S1134-80462011000200006.

  20. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012 ; 23 Suppl 7: Svii139-vii 54.

  21. Rodríguez RF, Daza P, Rodríguez MF. Tratamiento farmacológico del dolor en pacientes con cáncer. Colombia Médica [revista en Internet]. 2006 [ cited 14 Nov 2016 ] ; 37 (3): [aprox. 10p]. Available from: http://www.scielo.org.co/pdf/cm/v37n3/v37n3a10. pdf.

  22. Pharmacological Management of Cancer Pain in Adults. National Clinical Guideline No. 9 [Internet]. Dublin: National Clinical Effectiveness Committee; 2015. [ cited 25 Mar 2017 ] Available from: http://www.health.gov.ie/patient-safety/ncec.

  23. Guzmán M, Mora R, Delgado CM, Pérez A, Rueda M. Manejo del dolor crónico en Atención Primaria. Perfil de prescripción. Rev Soc Esp Dolor [revista en Internet]. 2014 [ cited 30 Nov 2017 ] ; 21 (4): [aprox. 16p]. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext &pid=S1134-80462014000400003.

  24. Guevara U. Terapia analgésica en el dolor oncológico. Revista Mexicana de Anestesiología [revista en Internet]. 2013 [ cited 20 Mar 2018 ] ; 36 (1): [aprox. 7p]. Available from: https://www.medigraphic.com/pdfs/rma/cma-201 3/cmas131ad.pdf.

  25. Majumdar S, Das A, Kundu R, Mukherjee D, Hazra B, Mitra T. Intravenous paracetamol infusion: Superior pain management and earlier discharge from hospital in patients undergoing palliative head-neck cancer surgery. Perspect Clin Res [revista en Internet]. 2014 Oct [ cited 12 Mar 2018 ] ; 5 (4): [aprox. 6p]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC41 70535/.

  26. Cazacu I, Mogosan C, Loghin F. Safety issues of current analgesics: an update. Clujul Med [revista en Internet]. 2015 [ cited 17 Dic 2017 ] ; 88 (2): [aprox. 9p]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC45 76793/.

  27. Kane CM, Hoskin P, Bennett MI. Cancer induced bone pain. Br Med J [revista en Internet]. 2015 [ cited 25 Nov 2017 ] ; 350 (Jan): [aprox. h315p]. Available from: https://www.bmj.com/content/350/bmj.h315.

  28. Garzón C, Casals M, Calsina A, López E, Porta J. Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results. Support Care Cancer. 2013 ; 21 (11): 3153-8.

  29. Zgaia AO, Irimie A, Sandesc D, Vlad C, Lisencu C, Rogobete A, et al. The role of ketamine in the treatment of chronic cancer pain. Clujul Med. 2015 ; 88 (4): 457-61.

  30. Moore A, Wiffen P, Kalso E. Antiepileptic drugs for neuropathic pain and fibromyalgia. JAMA. 2014 ; 312 (2): 182-3.

  31. Trescot AM, Datta S, Lee M, Hansen H. Opioid Pharmacology. Pain Physician. 2008 ; 11 (2): S133-53.

  32. Straube C, Derry S, Jackson KC, Wiffen PJ, Bell RF, Strassels S, et al. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst Rev. 2014 (9): CD006601.

  33. Ibáñez S, Morales Mas C, Callejas M, Mauro Placido J, Gálvez R. Terapéutica: Tratamiento del dolor. In: Formación continuada para farmacéuticos de hospital [Internet]. Barcelona: Universidad de Barcelona; 2000. [ cited 11 Mar 2018 ] Available from: http://www.ub.edu/legmh/capitols/ibanyez.pdf.

  34. The National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). Adult cancer pain [Internet]. Plymouth Meeting, PA: NCCN; 2016. [ cited 14 Mar 2018 ] Available from: https://www.nccn.org/professionals/physician_gls/ default.aspx.

  35. Bandieri E, Romero M, Ripamonti CI, Artioli F, Sichetti D, Fanizza C, et al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016 ; 34 (5): 436-42.

  36. Alfonso I, Alonso L, Alonso P, Broche L, Calvo DM, Gonzales Y, et al. Formulario Nacional de Medicamentos [Internet]. 4ta. ed. La Habana: Ecimed; 2014. [ cited 17 Nov 2017 ] Available from: https://instituciones.sld.cu/hospmiguelenriquez/fil es/2018/01/Formulario-nacional-de-medicamento s.pdf.

  37. Good P, Afsharimani B, Movva R, Haywood A, Khan S, Hardy J. Therapeutic challenges in cancer pain management: a systematic review of methadone. J Pain Palliat Care Pharmacother. 2014 ; 28 (3): 197-205.

  38. Hadley G, Derry S, Moore R, Wiffen P. Fentanilo transdérmico para el dolor por cáncer. Cochrane Database Syst Rev. 2013 (10): CD010270.

  39. Schmidt-Hansen M, Bennett MI, Arnold S, Bromham N, Hilgart JS. Oxycodone for cancer related pain. Cochrane Database Syst Rev. 2017 ; 8: CD003870.

  40. Naing C, Yeoh PN, Aung K. A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain. Springerplus. 2014 ; 3: 87.

  41. Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, et al. The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014 ; 39 (6): 577-83.

  42. Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf. 2015 ; 6 (1): 20-31.

  43. Portenoy RK, Ahmed E. Principles of Opioid Use in Cancer Pain. J Clin Oncol. 2014 ; 32 (16): 1662-70.




2020     |     www.medigraphic.com